Figure 1.
Body weight, locomotor activity, energy expenditure, and fat oxidation of Lepob/+/GIP+/+, Lepob/ob/GIP+/+, and Lepob/ob/GIPgfp/gfp male mice. (A) Body weight tracking of Lepob/+/GIP+/+ (white circles), Lepob/ob/GIP+/+ (gray circles), and Lepob/ob/GIPgfp/gfp mice (black circles) in cohort 1 (n = 5–8) and cohort 2 (n = 4–6). (B) Locomotor activity, energy expenditure and fat oxidation of Lepob/+/GIP+/+ (white bars), Lepob/ob/GIP+/+ (gray bars), and Lepob/ob/GIPgfp/gfp mice (black bars) at 34–35 weeks of age in cohort 2 (n = 3–6). *P < 0.05, **P < 0.01, ***P < 0.001 compared to Lepob/ob/GIP+/+. n.s; not significantly different. Data are mean ± SEM.